Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration-Reference-Cited by-同舟云学术

Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration

Published:1989-06 Issue:2-3 Volume:77 Page:139-149
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Malmendier C.L.,Lontie J.-F.,Delcroix C.,Dubois D.Y.,Magot T.,De Roy L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. A specific apoprotein activator for lipoprotein lipase;LaRosa;Biochem. Biophys. Res. Commun.,1970

2. Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein;Brown;Biochem. Biophys. Res. Commun.,1972

3. Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects;Kashyap;J. Clin. Invest.,1977

4. Apolipoprotein C-II and C-III levels in hyperlipoproteinemia;Schonfeld;Metabolism,1979

5. Effects of short-term high carbohydrate, fat-free diet on plasma levels of apo C-II and apo C-III and on the apo C subspecies in human plasma lipoproteins;Falko;Metabolism,1980

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peroxisome Proliferator-Activated Receptor α in Lipoprotein Metabolism and Atherosclerotic Cardiovascular Disease;Biomedicines;2023-10-03

2. Present and Future of Dyslipidaemia Treatment—A Review;Journal of Clinical Medicine;2023-09-08

3. Fibrates Revisited: Potential Role in Cardiovascular Risk Reduction;Diabetes & Metabolism Journal;2020

4. Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia;Annals of Clinical Biochemistry: International Journal of Laboratory Medicine;2019-03-19

5. Adverse Effects of Fenofibrate in Mice Deficient in the Protein Quality Control Regulator, CHIP;Journal of Cardiovascular Development and Disease;2018-08-15